YARS1 and peripheral neuropathy: These findings indicate that the loss of aminoacylation activity is neither necessary nor sufficient to cause peripheral neuropathy, suggesting that TyrRS‐linked neurodegeneration results from a gain‐of‐function of TyrRS variants separate from aminoacylation.